J10 Category · further specificity required Influenza due to other identified influenza virus
ICD-10-CM J10 identifies “Influenza due to other identified influenza virus” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 10: Diseases of the respiratory system
Code-level instructions
Includes3
- influenza A (non-novel)
- influenza B
- influenza C
Inherited instructions
Chapters 10 · Diseases of the respiratory system (J00-J99)
Excludes 29
- certain conditions originating in the perinatal period (P04-P96)
- certain infectious and parasitic diseases (A00-B99)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- smoke inhalation (T59.81-)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
Use additional code7
Note1
When a respiratory condition is described as occurring in more than one site and is not specifically indexed, it should be classified to the lower anatomic site (e.g. tracheobronchitis to bronchitis in J40).
J09-J18 · Influenza and pneumonia (J09-J18)
Excludes 29
Use additional code1
code, if applicable, to identify resistance to antimicrobial drugs (Z16.-)
More specific codes
J10.0Influenza due to other identified influenza virus with pneumoniaCategory · further specificity requiredJ10.1Influenza due to other identified influenza virus with other respiratory manifestationsBillable / specificJ10.2Influenza due to other identified influenza virus with gastrointestinal manifestationsBillable / specificJ10.8Influenza due to other identified influenza virus with other manifestationsCategory · further specificity requiredOfficial index references
Official index references (3)
Influenza(bronchial) (epidemic) (respiratory (upper)) (unidentified influenza virus) (3)
- Influenza(bronchial) (epidemic) (respiratory (upper)) (unidentified influenza virus) › A(non-novel)Disease index
- Influenza(bronchial) (epidemic) (respiratory (upper)) (unidentified influenza virus) › BDisease index
- Influenza(bronchial) (epidemic) (respiratory (upper)) (unidentified influenza virus) › CDisease index
References from other codes (5)
Excludes 1 · influenza A/H1N1 (J10.-)
Excludes 1 · influenza due to other identified influenza virus (J10.-)
Excludes 1 · seasonal influenza due to other identified influenza virus (J10.-)
Inclusion terms · Newborn affected by maternal infectious disease classifiable to A00-B99, J09 and J10
Excludes 2 · infectious diseases not specific to the perinatal period (A00-B99, J09, J10.-)
History
Code history
Latest recorded change · FY2024
Effective from
- Inherited rules changed
Influenza due to other identified influenza virus
Category — select a more specific code
CDC/NCHS · FY2024All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | Inherited rules changed |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | Code-level rules changed |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | Inherited rules changed |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.